Shanghai Aladdin Biochemical Technology Co.,Ltd. Stock
Equities
688179
CNE100005XD0
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
16.62 CNY | -2.41% | +3.68% | -13.26% |
Sales 2024 * | 512M 70.87M | Sales 2025 * | 661M 91.5M | Capitalization | 3.29B 456M |
---|---|---|---|---|---|
Net income 2024 * | 177M 24.5M | Net income 2025 * | 228M 31.56M | EV / Sales 2024 * | 6.43 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 4.98 x |
P/E ratio 2024 * |
13.3
x | P/E ratio 2025 * |
10.3
x | Employees | 566 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 50.04% |
1 day | -2.41% | ||
1 week | +3.68% | ||
Current month | +3.68% | ||
1 month | +6.33% | ||
3 months | +27.65% | ||
6 months | -20.06% | ||
Current year | -13.26% |
Managers | Title | Age | Since |
---|---|---|---|
Jiu Zhen Xu
CEO | Chief Executive Officer | 58 | - |
Hong Bao Shen
DFI | Director of Finance/CFO | 41 | - |
Wei Yu Gu
DFI | Director of Finance/CFO | 49 | 11-02-28 |
Members of the board | Title | Age | Since |
---|---|---|---|
Xin An Zhao
BRD | Director/Board Member | 55 | 13-10-31 |
Jiu Zhen Xu
CEO | Chief Executive Officer | 58 | - |
Kun Wang
ADM | Chief Administrative Officer | 44 | 11-02-28 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-10 | 16.62 | -2.41% | 3,749,557 |
24-05-09 | 17.03 | +0.12% | 3,897,039 |
24-05-08 | 17.01 | -0.82% | 5,275,522 |
24-05-07 | 17.15 | +1.00% | 3,822,123 |
End-of-day quote Shanghai S.E., May 09, 2024
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.26% | 456M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+48.77% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- 688179 Stock